Abbott Immunoassay Reagent Abbott Antibody Test SARS-CoV-2 IgG For Architect i Systems 100 Tests - KT/100 - 06R8620-KT

Abbott Immunoassay Reagent Abbott Antibody Test SARS-CoV-2 IgG For Architect i Systems 100 Tests - KT/100 - 06R8620-KT

Regular price $1,095.99
Sale price $1,095.99 Regular price
OFF Sold out
Shipping calculated at checkout.

50 In stock

Estimated deliver:

Flat-Rate Shipping from $8.25

  • American Express
  • Diners Club
  • Discover
  • Mastercard
  • Shop Pay
  • Visa
View full details
Reviews

Abbott Immunoassay Reagent Abbott Antibody Test SARS-CoV-2 IgG For Architect i Systems 100 Tests ...

Item Id 1164346
MF Id# 06R8620
Brand Abbott
Manufacturer Abbott
Country of Origin Ireland
Application Immunoassay Reagent
Container Type Vial
For Use With For Architect i Systems
Is_Active_Vendor Y
Is_DSCSA N
Is_Discontinued N
Is_Medical_Device N
Lot_Tracking_Flag N
Number of Tests 100 Tests
On_Allocation N
Product Dating McKesson Acceptable Dating: we will ship >= 90 days
Sample Type Serum / Plasma Sample
Storage Requirements Requires Refrigeration
Supplier_ID 4446496
Test Method Chemiluminescent Microparticle Immunoassay (CMIA)
Test Name SARS-CoV-2 IgG
Test Type Antibody Test
UNSPSC Code 41116010

Features

  • The SARS-CoV-2 IgG assay is ONLY for use under the Food and Drug Administration’s Emergency Use Authorization: https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations
  • The SARS-CoV-2 IgG assay is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection; at this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity
  • The SARSCoV-2 IgG assay should not be used to diagnose acute SARS-CoV-2 infection
  • Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) of 1988, 42 U.S.C 263a, to perform moderate or high complexity test
  • Laboratories within the United States and its territories are required to report all positive results to the appropriate public health authorities
  • Negative results do not preclude acute SARS-CoV-2 infection
  • If acute infection is suspected, direct testing for SARS-CoV-2 is necessary
  • False positive results for SARS-CoV-2 IgG assay may occur due to cross-reactivity from pre-existing antibodies or other possible causes
  • Kit contents include: (100) Tests, 6.6 mL Microparticles, 5.8 mL Conjugate, 7.9 mL Assay Diluent

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
About your query!
Recently Viewed